Rasio Therapeutics, Inc., is a Maryland-based biopharmaceutical company that develops novel medicines using a cutting edge-computer aided drug design technology. Rasio has partnered with SilcsBio, a leader in computational drug discovery, to develop small molecules for exciting but previously inaccessible disease targets. Rasio is initially focusing on oncology and has raised seed funding to design and develop several oncology therapeutics for areas of significant unmet medical need.
Company Details
- Employees
- 2
- Founded
- -
- in****@****Tx.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- rasiotx.com
Rasio Therapeutics, Inc. Questions
Rasio Therapeutics, Inc.'s website is rasiotx.com
Rasio Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/rasio-therapeutics-inc
Rasio Therapeutics, Inc. has
2 employees.
View email and phone details for 2
employees at Rasio Therapeutics, Inc..
Rasio Therapeutics, Inc.'s industry is
Pharmaceutical Manufacturing
Rasio Therapeutics, Inc.'s top competitors are
Coral (Acquihired),
Sporos Bioventures,
Biohealth Innovation, Inc.,
Silcsbio,
Mit Logística,
Unitrading Logistics,
Redesign Science,
Scribio,
Predix Pharmaceuticals,
Korro Bio, Inc..
Rasio Therapeutics, Inc.'s support email address is info@RasioTx.com
Rasio Therapeutics, Inc.'s categories are Pharmaceutical Manufacturing
Rasio Therapeutics, Inc.'s founding year is 2019
